| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $83,884,086 ) (Continued on the next page) |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01CA262675 | Minimizing salivary gland and renal toxicity arising from PSMA-targeted alpha therapy | 000 | 5 | NIH | 4/28/2026 | $678,197 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01CA274249 | Understanding resistance mechanisms to protein arginine methyltransransferase Inhibitors in Lymphoma | 000 | 4 | NIH | 2/26/2026 | $694,645 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R35GM144046 | Regulation of protein multi-functionality by 3 UTRs | 001 | 5 | NIH | 3/11/2026 | $70,800 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R35GM144046 | Regulation of protein multi-functionality by 3 UTRs | 000 | 5 | NIH | 12/15/2025 | $637,200 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R35GM152017 | Teaching free energy calculations to learn | 000 | 3 | NIH | 2/26/2026 | $538,560 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R35GM156454 | Decoding the Ubiquitin and Autophagy Signaling Networks | 000 | 2 | NIH | 2/19/2026 | $440,000 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R35GM126907 | Mechanisms of DNA Replication, Chromosome Compaction, and Chromosome Unlinking | 000 | 9 | NIH | 4/2/2026 | $1,044,132 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R35GM126945 | Mechanisms of DNA and RNA Transactions | 000 | 9 | NIH | 4/2/2026 | $1,083,240 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R35GM131921 | Mechanisms of Ion Channels and Enzymatic Membrane Proteins | 000 | 8 | NIH | 4/2/2026 | $950,400 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R21NS144867 | Characterization and Inhibition of the Interactions of the Alpha-Secretase ADAM17 with the Neuronal-Myelin Signaling Complex Upon Spinal Cord Injury | 000 | 1 | NIH | 5/5/2026 | $484,000 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R25CA214255 | Quantitative Sciences Summer Undergraduate Research Experience (QSURE) | 001 | 9 | NIH | 3/30/2026 | $51,007 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R25CA214255 | Quantitative Sciences Summer Undergraduate Research Experience (QSURE) | 000 | 9 | NIH | 12/11/2025 | $102,666 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R25CA272282 | Genomics Research Experience for Master's Students (GEMS) Fellowship | 000 | 4 | NIH | 4/21/2026 | $76,412 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R25CA236579 | Geriatric Oncology: Cognition and Communication | 001 | 7 | NIH | 4/17/2026 | $31,907 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R25CA236579 | Geriatric Oncology: Cognition and Communication | 000 | 7 | NIH | 1/29/2026 | $236,060 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R25CA020449 | Summer research experiences for medical students supervised by faculty mentors | 001 | 46 | NIH | 4/16/2026 | $34,873 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R25CA020449 | Summer research experiences for medical students supervised by faculty mentors | 000 | 46 | NIH | 1/28/2026 | $313,861 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R21CA296688 | Multiparametric endoscopic ultrasound for improved pancreatic cancer screening and characterization | 001 | 2 | NIH | 4/16/2026 | $20,569 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R21CA296688 | Multiparametric endoscopic ultrasound for improved pancreatic cancer screening and characterization | 000 | 2 | NIH | 1/6/2026 | $185,131 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R21CA301202 | Innate & Adaptive Determinants of Post-CAR Cytokine Release Syndrome | 000 | 1 | NIH | 3/31/2026 | $452,540 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R21CA292178 | Targeting Chromosomal Instability in the Evolution of Resistance to Matched Therapies Against Colorectal Cancer to Extend Treatment Response | 000 | 2 | NIH | 2/27/2026 | $246,840 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01NS126921 | Chemical Genetic Dissection of SWI/SNF Chromatin Remodeling Complex Functions in Cerebral Cortex Development | 000 | 4 | NIH | 4/2/2026 | $565,593 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01MH135403 | Human PSC-based cortical organoid and assembloid systems integrating pericyte and microglial lineages and signals | 000 | 3 | NIH | 12/2/2025 | $706,519 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01MD020111 | Family COMIDA (Consumo de Opciones Más Ideales De Alimentos) (Eating More Ideal Food Options) | 001 | 2 | NIH | 2/22/2026 | $74,849 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01MD020111 | Family COMIDA (Consumo de Opciones Más Ideales De Alimentos) (Eating More Ideal Food Options) | 000 | 2 | NIH | 1/2/2026 | $673,652 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01MD019804 | RSMI HEALS | 000 | 3 | NIH | 3/4/2026 | $738,562 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01MD016908 | Taxi ROADmAP (Realizing Optimization Around Diet And Physical activity) | 001 | 5 | NIH | 2/17/2026 | $71,885 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01MD016908 | Taxi ROADmAP (Realizing Optimization Around Diet And Physical activity) | 000 | 5 | NIH | 1/23/2026 | $646,946 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01HL164902 | Intestinal microbiome restoration in allogeneic stem cell transplantation | 001 | 4 | NIH | 3/24/2026 | $442,500 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01HL125571 | Regulation of the intestinal stem cell compartment after hematopoietic transplantation | 000 | 7 | NIH | 5/1/2026 | $766,768 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01GM149915 | Structural Mechanisms of DNA Damage Sensing and Activation of the ATR, Fanconi Anemia, and ATM Checkpoints | 000 | 4 | NIH | 4/17/2026 | $672,595 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01GM152927 | In vivio single-cell analysis of dynamic cell behaviors | 001 | 3 | NIH | 2/24/2026 | $439,849 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01GM152667 | Mechanism and Significance of HMG Co-A Synthase 1 Degradation | 000 | 3 | NIH | 4/2/2026 | $366,810 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01HD108914 | Essential roles for RNAi/hpRNAs to resolve intragenomic conflicts in the male germline | 000 | 5 | NIH | 4/1/2026 | $579,937 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01HD110120 | Structural and functional principles underlying germline genome transmission | 000 | 5 | NIH | 5/4/2026 | $488,964 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01HD112624 | Germline mutagenesis at meiotic double-strand breaks | 000 | 4 | NIH | 4/28/2026 | $449,178 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01GM129058 | Replication Of Chromosomes In Budding Yeast | 001 | 7 | NIH | 3/20/2026 | $45,762 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01GM129058 | Replication Of Chromosomes In Budding Yeast | 000 | 7 | NIH | 12/11/2025 | $411,861 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | UG1CA233290 | Network Lead Academic Participating Site: Memorial Sloan Kettering Cancer Center | 001 | 7 | NIH | 5/11/2026 | $1,055,000 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | UH3CA290241 | CD28-KITv CAR T cells with PD-1 dominant negative receptor | 000 | 3 | NIH | 5/7/2026 | $2,639,991 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | U24CA285296 | ISIC-REPO; ISIC Skin Imaging Repository Enhancements for Promoting Interoperability and Utilization | 001 | 3 | NIH | 4/28/2026 | $696,147 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | U01AI187049 | Anti-ceramide Ab Preserves Intestinal Stem Cells and Prevents GI-ARS and GI-DEARE | 000 | 2 | NIH | 1/7/2026 | $616,000 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | T32CA009207 | Investigational Cancer Therapeutics Training Program (ICTTP) | 000 | 47 | NIH | 4/21/2026 | $6,000 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R35GM156616 | Molecular mechanisms of protein function | 000 | 2 | NIH | 5/12/2026 | $732,160 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R37CA244911 | Targeting stem-like cells and their niche in pancreatic cancer | 001 | 7 | NIH | 4/16/2026 | $49,085 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R37CA244911 | Targeting stem-like cells and their niche in pancreatic cancer | 000 | 7 | NIH | 2/18/2026 | $441,764 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R35GM161744 | Investigating histone glycation as a new dynamic epigenetic mark | 000 | 1 | NIH | 4/6/2026 | $528,000 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R37CA295658 | Reproducible and Accurate PD-L1 Immunohistochemistry Biomarker Quantification Using Virtual Multiplex Immunofluorescence Restaining | 001 | 2 | NIH | 4/16/2026 | $67,401 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R37CA276200 | Defining the function of Complex I truncating mutations in cancer | 000 | 4 | NIH | 1/23/2026 | $431,336 |
|
